Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Humans (6)
- Male (6)
- Middle aged (6)
- Adult (5)
- Aged (5)
-
- Female (5)
- Middle Aged (5)
- Melanoma (4)
- Retrospective Studies (3)
- Retrospective studies (3)
- Uveal Neoplasms (3)
- Uveal melanoma (3)
- Uveal neoplasms (3)
- Diabetic retinopathy (2)
- Dry eye disease (2)
- Macular degeneration (2)
- Retina (2)
- Uveal Melanoma (2)
- Visual acuity (2)
- 80 and over (1)
- AA (1)
- AHA1 (1)
- AMD (1)
- Acetazolamide (1)
- Aged, 80 and over (1)
- Angiogenesis Inhibitors (1)
- Angiogenesis inhibitors (1)
- Animals (1)
- Anti-vegf (1)
- Antineoplastic Combined Chemotherapy Protocols (1)
- Publication Year
- Publication
-
- Wills Eye Hospital Papers (9)
- Annual Research Symposium (2)
- Kimmel Cancer Center Faculty Papers (2)
- PCOM Physician Assistant Studies Student Scholarship (2)
- Pharmacy Faculty Articles and Research (2)
-
- School of Medicine Faculty Publications (2)
- Articles (1)
- Capstone Showcase (1)
- Department of Pharmacology, Physiology, and Cancer Biology Faculty Papers (1)
- Dissertations and Theses (1)
- Electronic Theses and Dissertations (1)
- Faculty and Staff Scholarship (1)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (1)
- Journal of Mind and Medical Sciences (1)
- Mako: NSU Undergraduate Student Journal (1)
- Rowan-Virtua Research Day (1)
- School of Graduate Studies Faculty Publications (1)
- School of Medicine Publications (1)
- Publication Type
- File Type
Articles 31 - 31 of 31
Full-Text Articles in Eye Diseases
Is Besifloxacin Ophthalmic Suspension 0.6% Safe And Effective For The Treatment Of Bacterial Conjunctivitis?, Hetal R. Desai
Is Besifloxacin Ophthalmic Suspension 0.6% Safe And Effective For The Treatment Of Bacterial Conjunctivitis?, Hetal R. Desai
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this systematic review is to determine whether or not besifloxacin ophthalmic suspension 0.6% is safe and effective for the treatment of bacterial conjunctivitis.